News & Events about Veru Inc.
Veru Inc. (NASDAQ:VERU Get Rating) was the target of a significant growth in short interest during the month of April. As of April 15th, there was short interest totalling 15,820,000 shares, a growth of 17.4% from the March 31st total of 13,480,000 shares. Approximately 26.5% of the shares ...
Veru Inc. (NASDAQ:VERU Get Rating) was the target of a significant growth in short interest during the month of April. As of April 15th, there was short interest totalling 15,820,000 shares, a growth of 17.4% from the March 31st total of 13,480,000 shares. Approximately 26.5% of the shares of the ...
NEW YORK, March 13, 2023 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that it is investigating whether the directors and/or officers of Veru, Inc. (Veru or the Company) (NASDAQ: VERU) breached their fiduciary duties of loyalty, good faith and candor and whether the Company suffered ...
MIAMI, FL., March 07, 2023 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel medicines for COVID-19 and other viral ARDS-related diseases and for oncology, today announced that Mitchell Steiner, M.D., Chairman, President and Chief Executive Officer...
SAN DIEGO, Feb. 24, 2023 (GLOBE NEWSWIRE) -- Generac Holdings Inc. (NYSE: GNRC) Johnson Fistel, LLP is investigating potential claims on behalf Generac Holdings Inc. (NYSE: GNRC) against certain of its officers and directors. If you are a current, long-term shareholder of Generac holding shares ...